Business Finance Contracts & Agreements in the Life Sciences Tools & Services Industry
1,929 Contracts & Agreements
- Assignment Agreements (10 contracts from 7 companies)
- Credit Agreements (153 | 28)
- Debenture Agreements (7 | 4)
- Equity Distribution Agreements (1 | 1)
- Escrow Agreements (5 | 4)
- Exchange Agreements (20 | 15)
- Facility Agreements (2 | 1)
- Financing Agreements (20 | 5)
- Funding Agreements (1 | 1)
- Guarantee Agreements (5 | 5)
- Guaranty Agreements (4 | 4)
- Indenture Agreements (106 | 16)
- Investment Agreements (4 | 3)
- Investor Rights Agreements (30 | 24)
- Joinder Agreements (3 | 1)
- Loan Agreements (137 | 30)
- Note Agreements (377 | 29)
- Participation Agreements (3 | 2)
- Pledge Agreements (2 | 2)
- Purchase Agreements (136 | 41)
- Registration Rights Agreements (60 | 27)
- Release Agreements (11 | 7)
- Repurchase Agreements (11 | 4)
- Security Agreements (22 | 13)
- Share Agreements (40 | 17)
- Shareholders Agreements (11 | 7)
- Stock Agreements (366 | 58)
- Subscription Agreements (13 | 9)
- Term Sheets (1 | 1)
- Trust Agreements (1 | 1)
- Underwriting Agreements (178 | 45)
- Waiver Agreements (6 | 3)
- Warrant Agreements (183 | 33)
- 10x Genomics, Inc. (18 contracts)
- AbCellera Biologics Inc. (5)
- AbSci Corp (6)
- Adaptive Biotechnologies Corp (11)
- Agilent Technologies Inc (79)
- Akoya Biosciences, Inc. (8)
- Alpha Teknova, Inc. (24)
- ArcherDX, Inc. (4)
- ARQULE INC (19)
- ARYA Sciences Acquisition Corp III (13)
- Avantor, Inc. (20)
- Basis Global Technologies, Inc. (7)
- Berkeley Lights, Inc. (15)
- Bio-Matrix Scientific Group, Inc. (86)
- Bio-Rad Laboratories (22)
- Bio-Techne (20)
- BIOANALYTICAL SYSTEMS INC (65)
- BioNano Genomics, Inc (81)
- BRUKER CORP (27)
- Cambrex Corporation (6)
- CHAMPIONS ONCOLOGY, INC. (21)
- Charles River Laboratories (20)
- ChromaDex Corp. (43)
- CM Life Sciences II Inc. (20)
- Codex DNA, Inc. (18)
- CODEXIS INC (50)
- Cytek BioSciences, Inc. (4)
- ECO SCIENCE SOLUTIONS, INC. (17)
- EMMAUS LIFE SCIENCES, INC. (213)
- EVIO, INC. (80)
- FLUIDIGM CORP (40)
- HARVARD BIOSCIENCE INC (32)
- HighCape Capital Acquisition Corp. (21)
- Illumina Inc (23)
- INTERNATIONAL ISOTOPES INC (1)
- InventaBioTech Inc. (2)
- IQVIA Holdings Inc. (44)
- IsoPlexis Corp (16)
- Lifesci Acquisition II Corp. (18)
- Luminex Corporation (32)
- MARAVAI LIFESCIENCES HOLDINGS, INC. (21)
- Medpace Holdings, Inc. (15)
- Mettler Toledo (14)
- Miromatrix Medical Inc. (21)
- NanoString Technologies Inc (35)
- NEOGENOMICS INC (37)
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (23)
- PerkinElmer (60)
- Personalis, Inc. (20)
- Pharma-Bio Serv, Inc. (10)
- PPD, Inc. (7)
- PRA Health Sciences (18)
- PRESSURE BIOSCIENCES INC (57)
- Quanterix Corp (23)
- RAPID MICRO BIOSYSTEMS, INC. (13)
- Repligen Corporation (21)
- Seer, Inc. (9)
- SeqLL, Inc. (52)
- Singular Genomics Systems, Inc. (10)
- Sotera Health Co (13)
- Syneos Health (43)
- Thermo Fisher Scientific (103)
- VG Acquisition Corp. (25)
- Waters Corporation (28)
- Limited Guarantee, dated as of December 22, 2024, by and between Deerfield Private Design Fund IV, L.P., and Singular Genomics Systems, Inc (Singular Genomics Systems, Inc., Filed With SEC on December 23, 2024)
- Investment Agreement, dated December 19, 2024, by and between Personalis, Inc. and Merck Sharp & Dohme LLC (Personalis, Inc., Filed With SEC on December 19, 2024)
- Underwriting Agreement, dated as of December (BIOANALYTICAL SYSTEMS INC, Filed With SEC on December 18, 2024)
- Share Purchase Agreement, dated December 16, 2024, by and among Quanterix Corporation (Quanterix Corp, Filed With SEC on December 17, 2024)
- Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement (2025 RSU Award) (MARAVAI LIFESCIENCES HOLDINGS, INC., Filed With SEC on December 5, 2024)
- Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement (2024 RSU Award) (MARAVAI LIFESCIENCES HOLDINGS, INC., Filed With SEC on December 5, 2024)
- Description of Capital Stock (BIOANALYTICAL SYSTEMS INC, Filed With SEC on December 4, 2024)
- Amendment No. 3 to Stock Purchase Agreement, dated October 23, 2024, by and among Envigo Global Services, Inc., Inotiv, Inc. and Orient Bio, Inc (BIOANALYTICAL SYSTEMS INC, Filed With SEC on December 4, 2024)
- Amendment No. 2 to Stock Purchase Agreement (BIOANALYTICAL SYSTEMS INC, Filed With SEC on December 4, 2024)
- Amendment No. 4 to Credit and Security Agreement, dated July 31, 2024, by and between the Registrant and Midcap Financial Trust (Akoya Biosciences, Inc., Filed With SEC on November 14, 2024)
- Form of Securities Purchase Agreement dated October 30, 2024, between Bionano Genomics, Inc. and the purchasers party thereto (BioNano Genomics, Inc, Filed With SEC on October 31, 2024)
- Form of Series D Warrant (BioNano Genomics, Inc, Filed With SEC on October 31, 2024)
- Form of Series C Warrant (BioNano Genomics, Inc, Filed With SEC on October 31, 2024)
- Amendment to the Codexis, Inc. 2023 Employee Stock Purchase Plan (CODEXIS INC, Filed With SEC on October 31, 2024)
- Form of 2019 Employee Stock Purchase Plan Subscription Agreement (10x Genomics, Inc., Filed With SEC on October 29, 2024)
- 23andMe Holding Co. Amended and Restated Employee Stock Purchase Plan (VG Acquisition Corp., Filed With SEC on October 16, 2024)
- Amendment No. 1 to Convertible Promissory Note dated as of September 12, 2024 made by the issuer to IDC Technologes Inc (SeqLL, Inc., Filed With SEC on September 16, 2024)
- Letter dated September 16, 2024 to the shareholders of record as of September 26, 2023 (SeqLL, Inc., Filed With SEC on September 16, 2024)
- Officers Certificate, dated September 9, 2024, setting forth the terms and form of the Notes (Illumina Inc, Filed With SEC on September 9, 2024)
- Underwriting Agreement, dated September 4, 2024, between the Company and J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC, as representatives of the several underwriters... (Illumina Inc, Filed With SEC on September 9, 2024)
- Third Supplemental Indenture, dated as of September 9, 2024, between the Company and Citibank, N.A (Agilent Technologies Inc, Filed With SEC on September 9, 2024)
- Second Supplemental Indenture, dated as of September 9, 2024, between the Company and Citibank, N.A (Agilent Technologies Inc, Filed With SEC on September 9, 2024)
- Underwriting Agreement, dated September 4, 2024, among the Company, Citigroup Global Markets Inc., as underwriter, and the selling stockholders named in Schedule 2 thereto (Sotera Health Co, Filed With SEC on September 6, 2024)
- Underwriting Agreement, dated September 4, 2024, by and among the Company, BofA Securities, Inc., J.P. Morgan Securities LLC, Mizuho Securities USA LLC and Wells Fargo Securities,... (Agilent Technologies Inc, Filed With SEC on September 5, 2024)
- Description of Capital Stock attached as Exhibit 4.1 hereto (Bio-Techne, Filed With SEC on August 22, 2024)
- Investment Agreement, dated August 16, 2024, by and between Personalis, Inc. and Tempus AI, Inc (Personalis, Inc., Filed With SEC on August 16, 2024)
- Tenth Amendment to Loan Agreement and Forbearance Agreement (SeqLL, Inc., Filed With SEC on August 14, 2024)
- Ninth Amendment to ABL Credit Agreement and Forbearance Agreement (SeqLL, Inc., Filed With SEC on August 14, 2024)
- Sixth Amendment to Credit Agreement dated as of August 7, 2024, by and among Inotiv, Inc., certain subsidiaries of Inotiv, Inc., the lenders party thereto, and Jefferies Finance... (BIOANALYTICAL SYSTEMS INC, Filed With SEC on August 9, 2024)
- Most Favored Lender Notice, dated as of April 11, 2024, delivered by the Company to the Purchasers named in the Purchaser Schedule to the Note Purchase Agreement, dated as of... (BRUKER CORP, Filed With SEC on August 9, 2024)
- Most Favored Lender Notice, dated as of April 11, 2024, delivered by the Company to the Purchasers named in the Purchaser Schedule to the Note Purchase Agreement, dated as of... (BRUKER CORP, Filed With SEC on August 9, 2024)
- Amendment No. 1 to the Loan and Security Agreement by and between the Company and Innovatus Life Sciences Fund I, LP., effective as of February 13, 2024 (CODEXIS INC, Filed With SEC on August 8, 2024)
- Supplemental Indenture, dated as of June 27, 2024, among the subsidiary guarantors named on the signature pages thereto and U.S. Bank Trust Company, National Association, as... (IQVIA Holdings Inc., Filed With SEC on July 22, 2024)
- Supplemental Indenture, dated as of June 27, 2024, among the subsidiary guarantors named on the signature pages thereto and U.S. Bank Trust Company, National Association, as... (IQVIA Holdings Inc., Filed With SEC on July 22, 2024)
- Master Note Facility Agreement, dated as of July 12, 2024, by and among Waters Corporation, NYL Investors LLC (Waters Corporation, Filed With SEC on July 18, 2024)
- Form of Registration Rights Agreement, dated July 11, 2024 (Alpha Teknova, Inc., Filed With SEC on July 12, 2024)
- Form of Securities Purchase Agreement, dated July 11, 2024 (Alpha Teknova, Inc., Filed With SEC on July 12, 2024)
- Form of Securities Purchase Agreement dated July 4, 2024 between Bionano Genomics, Inc. and the purchasers party thereto (BioNano Genomics, Inc, Filed With SEC on July 8, 2024)
- Form of Series B Warrant (BioNano Genomics, Inc, Filed With SEC on July 8, 2024)
- Form of Series A Warrant (BioNano Genomics, Inc, Filed With SEC on July 8, 2024)
